Literature DB >> 9558540

The management of drooling in children and patients with mental and physical disabilities: a literature review.

I Hussein1, A E Kershaw, J F Tahmassebi, S A Fayle.   

Abstract

Amongst the duties of the paediatric dentist is the provision of oral care to patients with the problem of drooling. Many, but certainly not all, of these patients have physical and/or learning disabilities. Various methods have been advocated for the management of drooling in the paediatric patient and older patients with disabilities, including behavioural programmes, biofeedback techniques, physiotherapy, biofunctional oral appliances, medication and surgery. It is of paramount importance that the patients and/or carers understand the advantages and disadvantages of any treatment method being considered. The paediatric dentist has an important role to play in explaining the different options to the patients and carers, and in implementing some treatment modalities, particularly non-surgical approaches. Referral to surgical specialists should be seen as 'a last resort' and suggested only if other treatment methods have been exhausted. If pharmacological or surgical treatment is carried out, careful monitoring for the development of dental caries and other problems is essential. The aim of this paper is to provide the paediatric dentist with concise overall knowledge of the causes of drooling and treatment options available.

Entities:  

Mesh:

Year:  1998        PMID: 9558540     DOI: 10.1046/j.1365-263x.1998.00055.x

Source DB:  PubMed          Journal:  Int J Paediatr Dent        ISSN: 0960-7439            Impact factor:   3.455


  13 in total

Review 1.  Hypersalivation: update of the German S2k guideline (AWMF) in short form.

Authors:  Armin Steffen; Wolfgang Jost; Tobias Bäumer; Dirk Beutner; Sabine Degenkolb-Weyers; Martin Groß; Maria Grosheva; Samer Hakim; Kai G Kahl; Rainer Laskawi; Rebekka Lencer; Jan Löhler; Thekla Meyners; Saskia Rohrbach-Volland; Rainer Schönweiler; Sara-Christina Schröder; Sebastian Schröder; Heidrun Schröter-Morasch; Maria Schuster; Susanne Steinlechner; Roland Urban; Orlando Guntinas-Lichius
Journal:  J Neural Transm (Vienna)       Date:  2019-04-10       Impact factor: 3.575

2.  Salivary Amylase Level in Bronchoalveolar Fluid as a Marker of Chronic Pulmonary Aspiration in Children.

Authors:  Mutasim Abu-Hasan; Mai Elmallah; Dan Neal; James Brookes
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-09-01       Impact factor: 1.349

3.  Behavioural and physiological outcomes of biofeedback therapy on dental anxiety of children undergoing restorations: a randomised controlled trial.

Authors:  P Dedeepya; S Nuvvula; R Kamatham; S V S G Nirmala
Journal:  Eur Arch Paediatr Dent       Date:  2013-08-02

4.  Management of drooling in disabled patients with scopolamine patches.

Authors:  Abigail Mato; Jacobo Limeres; Inmaculada Tomás; Maria Muñoz; Concepción Abuín; Javier F Feijoo; Pedro Diz
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

5.  Three-year survival of ART high-viscosity glass-ionomer and resin composite restorations in people with disability.

Authors:  Gustavo F Molina; Denise Faulks; Ignacio Mazzola; Ricardo J Cabral; Jan Mulder; Jo E Frencken
Journal:  Clin Oral Investig       Date:  2017-05-25       Impact factor: 3.573

6.  Botulinum toxin in the treatment of drooling in tetraplegic patients with brain injury.

Authors:  Sung Hwa Ko; Yong Beom Shin; Ji Hong Min; Myung Jun Shin; Jae Hyeok Chang; Yong-Il Shin; Hyun-Yoon Ko
Journal:  Ann Rehabil Med       Date:  2013-12-23

7.  Comparing the Effect of Botulinum Toxin Type B Injection at Different Dosages for Patient with Drooling due to Brain Lesion.

Authors:  Hee Dong Park; Hyo Jae Kim; Sang Jun Park; Yong Min Choi
Journal:  Ann Rehabil Med       Date:  2012-12-28

8.  Management of drooling for patients in the north of Iran: Analysis of the surgical management.

Authors:  Seyed Ebrahim Naghavi; Mir Mohammad Jalali
Journal:  J Res Med Sci       Date:  2010-01       Impact factor: 1.852

9.  Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions.

Authors:  Robert S Zeller; Jennifer Davidson; Hak-Myung Lee; Paul F Cavanaugh
Journal:  Ther Clin Risk Manag       Date:  2012-01-25       Impact factor: 2.423

10.  The association of drooling and health-related quality of life in children with cerebral palsy.

Authors:  Shih-Chung Chang; Chin-Kai Lin; Li-Chen Tung; Nai-Yin Chang
Journal:  Neuropsychiatr Dis Treat       Date:  2012-12-11       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.